Association of White Blood Cell Count With Clinical Outcome Independent of Treatment With Alteplase in Acute Ischemic Stroke

Introduction Higher white blood cell (WBC) count is associated with poor functional outcome in acute ischemic stroke (AIS). However, little is known about whether the association is modified by treatment with intravenous alteplase. Methods WAKE-UP was a randomized controlled trial of the efficacy and safety of magnetic resonance imaging [MRI]-based thrombolysis in unknown onset stroke. WBC count was measured on admission and again at 22–36 h after randomization to treatment (follow-up). Favorable outcome was defined by a score of 0 or 1 on the modified Rankin scale (mRS) 90 days after stroke. Further outcome were stroke volume and any hemorrhagic transformation (HT) that were assessed on follow-up CT or MRI. Multiple logistic regression analysis was used to assess the association between outcome and WBC count and treatment group. Results Of 503 randomized patients, WBC count and baseline parameters were available in 437 patients (μ = 64.7 years, 35.2% women) on admission and 355 patients (μ = 65.1 years, 34.1% women) on follow-up. Median WBC count on admission was 7.6 × 109/L (interquartile range, IQR, 6.1–9.4 × 109/L) and 8.2 × 109/L (IQR, 6.7–9.7 × 109/L) on follow-up. Higher WBC count both on admission and follow-up was associated with lower odds of favorable outcome, adjusted for age, National Institutes of Health (NIH) Stroke Scale Score, temperature, and treatment (alteplase vs. placebo, adjusted odds ratio, aOR 0.85, 95% confidence interval [CI] 0.78–0.94 and aOR 0.88, 95% CI 0.79–0.97). No interaction between WBC count and treatment group was observed (p = 0.11). Furthermore, WBC count on admission and follow-up was significantly associated with HT (aOR 1.14, 95% CI 1.05–1.24 and aOR 1.13, 95% CI 1.00–1.26). Finally, WBC count on follow-up was associated with larger stroke volume (aOR 2.57, 95% CI 1.08–6.07). Conclusion Higher WBC count is associated with unfavorable outcome, an increased risk of HT, and larger stroke volume, independent of treatment with alteplase. Whether immunomodulatory manipulation of WBC count improves stroke outcome needs to be tested. Trial Registration ClinicalTrials.gov Identifier: NCT01525290.

[1]  Fu-Liang Zhang,et al.  Association of admission leukocyte count with clinical outcomes in acute ischemic stroke patients undergoing intravenous thrombolysis with recombinant tissue plasminogen activator. , 2020, Current neurovascular research.

[2]  C. Anderson,et al.  Combined utility of blood glucose and white blood cell in predicting outcome after acute ischemic stroke: The ENCHANTED trial , 2020, Clinical Neurology and Neurosurgery.

[3]  C. Gerloff,et al.  Clinical Characteristics and Outcome of Patients With Hemorrhagic Transformation After Intravenous Thrombolysis in the WAKE-UP Trial , 2020, Frontiers in Neurology.

[4]  M. Elkind,et al.  Natalizumab in acute ischemic stroke (ACTION II) , 2020, Neurology.

[5]  M. Filippi,et al.  Leukocyte Counts and Ratios Are Predictive of Stroke Outcome and Hemorrhagic Complications Independently of Infections , 2020, Frontiers in Neurology.

[6]  M. Caulfield,et al.  White Blood Cells and Blood Pressure , 2020, Circulation.

[7]  S. Larsson.  with at a Mendelian randomization study. , 2020 .

[8]  Á. Chamorro,et al.  Leukocytes, Collateral Circulation, and Reperfusion in Ischemic Stroke Patients Treated With Mechanical Thrombectomy. , 2019, Stroke.

[9]  S. Zheng,et al.  Functional Dynamics of Neutrophils After Ischemic Stroke , 2019, Translational Stroke Research.

[10]  Luyun Chen,et al.  Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke. , 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[11]  Shengnan Wang,et al.  Association of lower leukocyte count before thrombolysis with early neurological improvement in acute ischemic stroke patients , 2018, Journal of Clinical Neuroscience.

[12]  A. Alexandrov,et al.  Differential leukocyte counts on admission predict outcomes in patients with acute ischaemic stroke treated with intravenous thrombolysis , 2018, European journal of neurology.

[13]  C. Gerloff,et al.  MRI‐Guided Thrombolysis for Stroke with Unknown Time of Onset , 2018, The New England journal of medicine.

[14]  Yongjun Cao,et al.  Prognostic Value of White Blood Cell Counts and C-reactive Protein in Acute Ischemic Stroke Patients After Intravenous Thrombolysis. , 2018, Current neurovascular research.

[15]  M. Elkind,et al.  Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial , 2017, The Lancet Neurology.

[16]  D. Leys,et al.  Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes , 2015, Neurology.

[17]  A. Demchuk,et al.  The Heidelberg Bleeding Classification: Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy. , 2015, Stroke.

[18]  F. Shi,et al.  Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial , 2015, Circulation.

[19]  Samantha J Walas,et al.  Neuregulin1-β Decreases IL-1β-Induced Neutrophil Adhesion to Human Brain Microvascular Endothelial Cells , 2014, Translational Stroke Research.

[20]  H. Heinze,et al.  Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke , 2015, Acta Neuropathologica.

[21]  Á. Chamorro,et al.  Neutrophil recruitment to the brain in mouse and human ischemic stroke , 2015, Acta Neuropathologica.

[22]  M. Gillette,et al.  Persistent leukocytosis-is this a persistent problem for patients with acute ischemic stroke? , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[23]  F. Silver,et al.  White blood cell count is an independent predictor of outcomes after acute ischaemic stroke , 2014, European journal of neurology.

[24]  A. Meretoja,et al.  Body Temperature, Blood Infection Parameters, and Outcome of Thrombolysis-Treated Ischemic Stroke Patients , 2013, International journal of stroke : official journal of the International Stroke Society.

[25]  P. Kubes,et al.  Neutrophil recruitment and function in health and inflammation , 2013, Nature Reviews Immunology.

[26]  A. Günther,et al.  a pilot trial , 2012 .

[27]  Karen Lowrie,et al.  Implications for risk assessment. , 2011, Risk analysis : an official publication of the Society for Risk Analysis.

[28]  C. Iadecola,et al.  The immunology of stroke: from mechanisms to translation , 2011, Nature Medicine.

[29]  Shih-Yi Lin,et al.  Differential White Blood Cell Count and Type 2 Diabetes: Systematic Review and Meta-Analysis of Cross-Sectional and Prospective Studies , 2010, PloS one.

[30]  R. Lichtinghagen,et al.  Linking infection and inflammation in acute ischemic stroke , 2010, Annals of the New York Academy of Sciences.

[31]  Eng H. Lo,et al.  The Science of Stroke: Mechanisms in Search of Treatments , 2010, Neuron.

[32]  Eng H. Lo,et al.  The Science of Stroke: Mechanisms in Search of Treatments , 2010, Neuron.

[33]  S. Lakhan,et al.  Inflammatory mechanisms in ischemic stroke: therapeutic approaches , 2009, Journal of Translational Medicine.

[34]  B. McColl,et al.  A Rapid and Transient Peripheral Inflammatory Response Precedes Brain Inflammation after Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  Christian Gerloff,et al.  Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. , 2009, Stroke.

[36]  B. McColl,et al.  Systemic infection, inflammation and acute ischemic stroke , 2009, Neuroscience.

[37]  S. Hopkins,et al.  Acute ischaemic stroke and infection: recent and emerging concepts , 2008, The Lancet Neurology.

[38]  N. Salamon,et al.  Early Neutrophilia Is Associated With Volume of Ischemic Tissue in Acute Stroke , 2008, Stroke.

[39]  M. Karjalainen‐Lindsberg,et al.  Mast Cell Stabilization Reduces Hemorrhage Formation and Mortality After Administration of Thrombolytics in Experimental Ischemic Stroke , 2007, Circulation.

[40]  R. Sacco,et al.  Relative elevation in baseline leukocyte count predicts first cerebral infarction , 2005, Neurology.

[41]  Dirk Sander,et al.  Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. , 2005, Stroke.

[42]  Imran Awan,et al.  Leukocyte count and coronary heart disease: implications for risk assessment. , 2004, Journal of the American College of Cardiology.

[43]  G. Boysen,et al.  C-Reactive Protein and White Blood Cell Count Increases in the First 24 Hours after Acute Stroke , 2004, Cerebrovascular Diseases.

[44]  R. Sacco,et al.  Leukocyte count predicts outcome after ischemic stroke: the Northern Manhattan Stroke Study. , 2004, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[45]  H. Audebert,et al.  Systemic Inflammatory Response Depends on Initial Stroke Severity but Is Attenuated by Successful Thrombolysis , 2004, Stroke.

[46]  W. Hacke,et al.  Leukocyte Count as an Independent Predictor of Recurrent Ischemic Events , 2004, Stroke.

[47]  Abdulmajeed Al Abdukareem.  Randomized, placebo-controlled trial , 2004, Annals of Saudi medicine.

[48]  R. Sacco,et al.  Elevated White Blood Cell Count and Carotid Plaque Thickness: The Northern Manhattan Stroke Study , 2001, Stroke.

[49]  C. Goetz,et al.  Therapeutic approaches. , 2000, Advances in neurology.

[50]  L Bozzao,et al.  Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. , 1999, Stroke.

[51]  N. Simonian,et al.  Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. , 1996, Stroke.

[52]  J. Garcìa,et al.  Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). , 1994, The American journal of pathology.

[53]  K. Anderson,et al.  White blood cell count and cardiovascular disease. Insights from the Framingham Study. , 1992, JAMA.

[54]  S. Wahl,et al.  Cytokines and neuropathology. , 1992, Trends in pharmacological sciences.

[55]  W. Weston,et al.  The Endotoxin‐induced Coagulant Activity of Human Monocytes , 1975, British journal of haematology.